| Neoadjuvant carboplatin/paclitaxel versus 5-fluorouracil/cisplatin in combination with radiotherapy for locally advanced esophageal squamous cell carcinoma: a multicenter … X Gao, PC Tsai, KH Chuang, CP Pai, PK Hsu, SH Li, HI Lu, ... Cancers 14 (11), 2610, 2022 | 9 | 2022 |
| PI3K inhibition reverses migratory direction of single cells but not cell groups in electric field Y Sun, H Yue, C Copos, K Zhu, Y Zhang, X Gao, Y Sun, B Reid, F Lin, ... bioRxiv, 2020 | 9 | 2020 |
| A novel tumor staging system incorporating tumor regression grade (TRG) with lymph node status (ypN-category) results in better prognostication than ypTNM stage groups after … IYH Wong, JCY Chung, RQ Zhang, X Gao, KO Lam, DLW Kwong, ... Annals of Surgery 276 (5), 784-791, 2022 | 8 | 2022 |
| Electric fields accelerate cell polarization and bypass myosin action in motility initiation YH Sun, Y Sun, K Zhu, B Reid, X Gao, BW Draper, M Zhao, A Mogilner Journal of cellular physiology 233 (3), 2378-2385, 2018 | 8 | 2018 |
| Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison BM Eyck, X Gao, Y Yang, BJ van der Wilk, I Wong, BPL Wijnhoven, J Liu, ... British Journal of Surgery 109 (12), 1312-1318, 2022 | 6 | 2022 |
| Clinical utility of circulating tumor cells for predicting major histopathological response after neoadjuvant chemoradiotherapy in patients with esophageal cancer X Gao, OQY Leow, CH Chiu, MM Hou, JCH Hsieh, YK Chao Journal of Personalized Medicine 12 (9), 1440, 2022 | 3 | 2022 |
| Unsuccessful stent graft repair of a hepatic artery aneurysm presenting with haemobilia: case report and comprehensive literature review X Gao, J de Jonge, H Verhagen, W Dinkelaar, S Ten Raa, MJ van Rijn EJVES Vascular Forum 52, 30-36, 2021 | 3 | 2021 |
| Thoracic surgery in Taiwan X Gao, YK Chao Journal of Thoracic Disease 14 (7), 2712, 2022 | 2 | 2022 |
| Safety and efficacy of cone-beam computed tomography-guided lung tumor localization with a near-infrared marker: a retrospective study of 175 patients CJ Chang, CH Lu, X Gao, HY Fang, YK Chao Life 12 (4), 494, 2022 | 2 | 2022 |
| Survival Outcomes of Patients with Esophageal Cancer Who Did Not Proceed to Surgery after Neoadjuvant Treatment CL Chi, X Gao, HY Hsieh, YH Cheng, ZH Yang, YK Chao Cancers 15 (16), 4049, 2023 | 1 | 2023 |
| Preoperative percutaneous localization of multiple ipsilateral pulmonary nodules: A systematic review CL Chi, X Gao, CC Tai, YK Chao Formosan Journal of Surgery 55 (3), 81-86, 2022 | 1 | 2022 |
| Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis X Gao, HCG Overtoom, BM Eyck, SH Huang, D Nieboer, PC van der Sluis, ... British Journal of Surgery 111 (5), znae083, 2024 | | 2024 |
| Esophageal Squamous Cell Carcinoma CJ vander Zijden, X Gao, B Mostert, MCW Spaander, M Doukas, ... Gastrointestinal Oncology‐A Critical Multidisciplinary Team Approach 2e, 82-115, 2024 | | 2024 |
| Collaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases X Leng, D Kurita, Y Zhu, S Abe, R Zhang, X Guo, L Dai, IYH Wong, ... Journal of Thoracic Disease 15 (11), 6362, 2023 | | 2023 |
| Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study X Gao, ZH Yang, YH Cheng, CL Chi, TY Yang, KH Chuang, CE Wu, ... Diseases of the Esophagus 36 (11), doad031, 2023 | | 2023 |
| 377. NEOADJUVANT CARBOPLATIN/PACLITAXEL VERSUS 5-FLUOROURACIL/CISPLATIN IN COMBINATION WITH RADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A MULTICENTER COMPARATIVE STUDY X Gao, PC Tsai, KH Chuang, CP Pai, PK Hsu, SH Lee, HI Lu, ... Diseases of the Esophagus 35 (Supplement_2), doac051. 377, 2022 | | 2022 |
| 343. THE RISK FACTORS OF HIATAL HERNIA IN ESOPHAGEAL CANCER PATIENTS WHO RECEIVED GASTRIC INTERPOSITION THROUGH POSTERIOR MEDIASTINAL ROUTE OQY Leow, YJ Yeow, KM Yeow, X Gao, YK Chao Diseases of the Esophagus 35 (Supplement_2), doac051. 343, 2022 | | 2022 |
| 387. REFUSING SURGERY AFTER NEOADJUVANT TREATMENT IN PATIENTS WITH ESOPHAGEAL CANCER: A PROPENSITY-SCORE MATCHED SURVIVAL ANALYSIS CL Chi, X Gao, YK Chao Diseases of the Esophagus 35 (Supplement_2), doac051. 387, 2022 | | 2022 |
| 508. OUTCOME OF NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN EAST ASIA VERSUS WESTERN EUROPE B Eyck, X Gao, Y Yang, B van der Wilk, I Wong, B Wijnhoven, J Liu, ... Diseases of the Esophagus 35 (Supplement_2), doac051. 508, 2022 | | 2022 |
| ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma—A Cost-Effectiveness Analysis G Xing, W Yu-Wen, C Yin-Kai Annals of Surgical Oncology 29 (6), 3656-3657, 2022 | | 2022 |
